Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

SVB Leerink Maintains Market Perform on Intercept Pharmaceuticals, Lowers Price Target to $21

SVB Leerink analyst Thomas Smith maintains Intercept Pharmaceuticals (NASDAQ:ICPT) with a Market Perform and lowers the price target from $27 to $21.
byBenzinga Newsdesk
July 8, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

SVB Leerink analyst Thomas Smith maintains Intercept Pharmaceuticals (NASDAQ:ICPT) with a Market Perform and lowers the price target from $27 to $21.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts